{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:37:49Z","timestamp":1770496669478,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2001,7,26]],"date-time":"2001-07-26T00:00:00Z","timestamp":996105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,7,26]],"date-time":"2001-07-26T00:00:00Z","timestamp":996105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2001,8,1]]},"DOI":"10.1038\/sj.leu.2402183","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T21:06:15Z","timestamp":1032469575000},"page":"1274-1276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Thalidomide for previously untreated indolent or smoldering multiple myeloma"],"prefix":"10.1038","volume":"15","author":[{"given":"SV","family":"Rajkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MQ","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JA","family":"Lust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RA","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PR","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MA","family":"Gertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TE","family":"Witzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,7,26]]},"reference":[{"key":"BF2402183_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","volume":"50","author":"RT Greenlee","year":"2000","unstructured":"Greenlee RT, Murray T, Bolden S, Wingo PA . Cancer statistics, 2000 CA Cancer J Clin 2000 50: 7\u201333","journal-title":"CA Cancer J Clin"},{"key":"BF2402183_CR2","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1056\/NEJM199706053362307","volume":"336","author":"R Bataille","year":"1997","unstructured":"Bataille R, Harousseau JL . Multiple myeloma N Engl J Med 1997 336: 1657\u20131664","journal-title":"N Engl J Med"},{"key":"BF2402183_CR3","first-page":"537","volume-title":"Neoplastic Diseases of the Blood","author":"PR Greipp","year":"1996","unstructured":"Greipp PR, Kyle RA . Staging, kinetics, and prognosis of multiple myeloma In: Wiernik PH, Canellos GP, Dutcher JP, Kyle RA (eds) Neoplastic Diseases of the Blood New York: Churchill Livingstone 1996 pp 537\u2013559"},{"key":"BF2402183_CR4","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJM198006123022405","volume":"302","author":"RA Kyle","year":"1980","unstructured":"Kyle RA, Greipp PR . Smoldering multiple myeloma N Engl J Med 1980 302: 1347\u20131349","journal-title":"N Engl J Med"},{"key":"BF2402183_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","volume":"87","author":"A Vacca","year":"1994","unstructured":"Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F . Bone marrow angiogenesis and progression in multiple myeloma Br J Haematol 1994 87: 503\u2013508","journal-title":"Br J Haematol"},{"key":"BF2402183_CR6","first-page":"3111","volume":"6","author":"SV Rajkumar","year":"2000","unstructured":"Rajkumar SV, Leong T, Roche PC, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Kyle RA, Gertz MA, Greipp PR . Prognostic value of bone marrow angiogenesis in multiple myeloma Clin Cancer Res 2000 6: 3111\u20133116","journal-title":"Clin Cancer Res"},{"key":"BF2402183_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/ctrv.2000.0188","volume":"26","author":"SV Rajkumar","year":"2000","unstructured":"Rajkumar SV, Witzig TE . A review of angiogenesis and anti-angiogenic therapy with thalidomide in multiple myeloma Cancer Treat Rev 2000 26: 351\u2013362","journal-title":"Cancer Treat Rev"},{"key":"BF2402183_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","volume":"341","author":"S Singhal","year":"1999","unstructured":"Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B . Antitumor activity of thalidomide in refractory multiple myeloma N Engl J Med 1999 341: 1565\u20131571","journal-title":"N Engl J Med"},{"key":"BF2402183_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.4065\/75.9.897","volume":"75","author":"SV Rajkumar","year":"2000","unstructured":"Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Kyle RA, Gertz MA, Greipp PR . Thalidomide in the treatment of relapsed multiple myeloma Mayo Clin Proc 2000 75: 897\u2013902","journal-title":"Mayo Clin Proc"},{"key":"BF2402183_CR10","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D'Amato","year":"1994","unstructured":"D'Amato RJ, Loughnan MS, Flynn E, Folkman J . Thalidomide is an inhibitor of angiogenesis Proc Natl Acad Sci USA 1994 91: 4082\u20134085","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2402183_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1006\/exer.1997.0292","volume":"64","author":"BM Kenyon","year":"1997","unstructured":"Kenyon BM, Browne F, D'Amato RJ . Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization Exp Eye Res 1997 64: 971\u2013978","journal-title":"Exp Eye Res"},{"key":"BF2402183_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/sj.leu.2401336","volume":"13","author":"SV Rajkumar","year":"1999","unstructured":"Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR . Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma Leukemia 1999 13: 469\u2013472","journal-title":"Leukemia"},{"key":"BF2402183_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1365-2141.2000.01835.x","volume":"108","author":"A Kneller","year":"2000","unstructured":"Kneller A, Raanani P, Hardan I, Avigdor A, Levi I, Berkowicz M, Ben-Bassat I . Therapy with thalidomide in refractory multiple myeloma \u2013 the revival of an old drug Br J Haematol 2000 108: 391\u2013393","journal-title":"Br J Haematol"},{"key":"BF2402183_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/j.1365-2141.2000.01983.x","volume":"109","author":"G Juliusson","year":"2000","unstructured":"Juliusson G, Celsing F, Turesson I, Lenhoff S, Adriansson M, Malm C . Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma Br J Haematol 2000 109: 89\u201396","journal-title":"Br J Haematol"},{"key":"BF2402183_CR15","first-page":"99a","volume":"92","author":"SV Rajkumar","year":"1998","unstructured":"Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR . Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma Blood 1998 92: (Suppl. 1) 99a","journal-title":"Blood"},{"key":"BF2402183_CR16","first-page":"98a","volume":"92","author":"N Munshi","year":"1998","unstructured":"Munshi N, Wilson CS, Penn J, Epstein J, Singhal S, Hough A, Sanderson R, Desikan R, Siegel D, Mehta J, Barlogie B . Angiogenesis in newly diagnosed multiple myeloma: poor prognosis with increased microvessel density (MVD) in bone marrow biopsies Blood 1998 92: (Suppl. 1) 98a","journal-title":"Blood"},{"key":"BF2402183_CR17","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","volume":"177","author":"AL Moreira","year":"1993","unstructured":"Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G . Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation J Exp Med 1993 177: 1675\u20131680","journal-title":"J Exp Med"},{"key":"BF2402183_CR18","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1084\/jem.187.11.1885","volume":"187","author":"PA Haslett","year":"1998","unstructured":"Haslett PA, Corral LG, Albert M, Kaplan G . Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset J Exp Med 1998 187: 1885\u20131892","journal-title":"J Exp Med"},{"key":"BF2402183_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0162-3109(95)00050-X","volume":"31","author":"H Geitz","year":"1996","unstructured":"Geitz H, Handt S, Zwingenberger K . Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade Immunopharmacology 1996 31: 213\u2013221","journal-title":"Immunopharmacology"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402183","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:31:52Z","timestamp":1648762312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,26]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8,1]]}},"alternative-id":["BF2402183"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402183","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7,26]]},"assertion":[{"value":"27 February 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}